New Scientific Discoveries | Novartis

Media Release
Oct 26, 2020
Novartis presents promising interim Phase II data of potential first-in-class oral therapy iptacopan (LNP023) in rare renal disease C3 glomerulopathy (C3G)
Media Release
Oct 29, 2020
Novartis acquires Vedere Bio, adding novel optogenetic gene therapy technology for treating blindness
Story
Sep 22, 2015
Stopping free radicals at their source
Story
Nov 26, 2018
Reimagining protein sequencing
Story
Jun 29, 2016
Molecular glue kills cancer cells in mice
Story
Jun 01, 2017
Minion challenges assumptions about the genome
Story
Dec 01, 2016
How Zika infects the growing brain
Story
Jan 18, 2016
How to address the culture gap between academia and industry in biomedicine
Story
Apr 05, 2016
Hooked on science, Jay Bradner becomes top researcher at Novartis
Story
Jun 01, 2015
Fixing what’s lost in translation
Story
May 09, 2016
Eye disease tracked to a glitch in starburst cells
Story
Jan 30, 2017
Countering the genome reprogramming of cancer cells